Download | < Back |
23 Nov 2020 | |
Recently published data on Favipiravir as treatment for mild to moderate COVID-19 demonstrates significant improvement in time to clinical cure | |
View all announcements for GLENMARK PHARMACEUTICALS LTD. | Source: BSE India |